Bradbeer C. Is infection with HIV a risk factor for cervical intraepithelial neoplasia? (Letter) . Lancet 1987;;2:1277-8.
Maiman M, Fruchter RG, Serur E, Boyce JG. Prevalence of human immunodeficiency virus in a colposcopy clinic (Letter) . JAMA 1988;;260:2214.
Provencher D, Valme B, Averette HE, et al. HIV status and positive Papanicolaou screening: identification of a high-risk population . Gynecol Oncol 1988;;31:184-8.
Henry MJ, Stanley MW, Cruikshank S, Carson L. Association of human immunodeficiency virusinduced immunosuppression with human papillomavirus infection and cervical intraepithelial neoplasia . Am J Obstet Gynecol 1989;;160:352-3.
Schrager LK, Friedland GH, Maude D, et al. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus . J Acquir Immune Defic Syndr 1989;;2:570-5.
Marte C, Cohen M, Fruchter R, Kelly P. Pap test and STD finding in HIV + women at ambulatory care sites (Abstract). VI International Conference on AIDS. Vol 2. San Francisco, June 20-24, 1990 :211.
Feingold AR, Vermund SH, Burk RD, et al. Cervical cytologic abnormalities and Papillomavirus in women infected with human immunodeficiency virus . J Acquir Immune Defic Syndr 1990;;3:896-903.
Vermund S, Kelley KF, Burk RD, et al. Risk of human papillomavirus (HPV) and cervical squamous intraepithelial lesions (SIL) highest among women with advanced HIV disease (Abstract). VI International Conference on AIDS. Vol 3. San Francisco, June 20-24,1990 :215.
Maiman M, Fruchter RG, Serur E, et al. Human immunodeficiency virus infection and cervical neoplasia . Gynecol Oncol 1990;;38:377-82.
Tarricone NJ, Maiman M, Vieira J. Colposcopic evaluation of HIV seropositive women (Abstract). VI International Conference on AIDS. Vol 2. San Francisco, June 20-24,1990 :378.
National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses . JAMA 1989;;262:931-4.
NovickLF, Berns D, Stricof R, Stevens R, Pass K, Wethers J. HIV seroprevalence in newborns in New York state . JAMA 1989;;261:1745-50.
New York State Department of Health. Time trends in cancer incidence: 1977-1986 . Albany, New York: New York State Cancer Registry, 1990;.
Chu SY, Buehler JW, Berkelman RL. Impact of the human immunodeficiency virus epidemic on mortality in women of reproductive age, United States . JAMA 1990;;264:225-9.
Munoz N, Bosch FX. Epidemiology of cervical cancer . In: Munoz N, Bosch FX, Jensen OM, eds. Human papillomavirus and cervical cancer . Lyon, France: International Agency for Research on Cancer (WHO), 1989;:9-39.
Fink DJ. Change in American Cancer Society checkup guidelines for detection of cervical cancer . CA 1988;;38:127-8.
US Department of Health and Human Services, Preventive Services Task Force. Screening for cervical cancer . In: Guide to clinical preventive services: an assessment of the effectiveness of 169 interventions . Baltimore: Williams and Wilkins, 1989;:57-62.
Low-grade SIL encompass cellular changes associated with human papillomavirus and mild dysplasia/cervical intraepithelial neoplasia (CIN) 1; high-grade SIL include moderate dysplasia/CIN 2, severe dysplasia/ CIN 3, and carcinoma-in-situ/CIN 3.